Skip to main content

Cronos stock falls after wider-than-expected loss, but revenue is boosted by Canadian adult-use cannabis market

Cronos Group Inc. shares slid 2.4% Friday, after the Canadian cannabis company posted a wider-than-expected loss for the fourth quarter, but revenue that beat estimates, buoyed by growth in the Canadian adult-use market and U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.